PDF By JANET ADAMY and GREG HITT
The drug industry stands to gain in a health-care overhaul by getting tens of millions of newly insured customers, while insurance companies — especially those that cater to the individual market — look like they are in for a tougher time.
That is the early scorecard from executives poring over Congress’s sweeping health legislation. Senate Democrats are meeting this week to write the bill they plan to bring to the floor, following last week’s 14-9 vote in the Senate Finance Committee for a health bill that would cost $829 billion over 10 years.
A plea for a more rational system
0 Responses to “CEOs Tally Health-Bill Score – WSJ.com”